Intuitive Surgical (NASDAQ:ISRG) EVP Sells $16,616.58 in Stock
📉 EVP Mark Brosius sold 46 shares of ISRG for $16,616.58 on September 8th under a pre-arranged Rule 10b5-1 trading plan.
💰 The company reported Q2 revenue of $2.89 billion, beating the consensus estimate of $2.83 billion by $0.06 billion.
📈 Intuitive Surgical posted EPS of $2.80 for the quarter, significantly exceeding analyst expectations of $2.48.
🚀 Revenue grew 18.4% year-over-year, demonstrating continued strong demand for the da Vinci Surgical System.
🏦 The stock trades at a P/E ratio of 40.46 with a market capitalization of $124.79 billion.
📊 Analyst consensus rating is 'Moderate Buy' with an average price target of $508.68.
Bullish Signals
- Intuitive Surgical beat quarterly revenue estimates by $0.06 billion, reporting $2.89 billion in revenue.
- The company significantly exceeded earnings expectations with EPS of $2.80 versus the consensus of $2.48.
- Revenue grew 18.4% year-over-year, indicating robust market expansion for its robotic surgical systems.
- KeyCorp and Piper Sandler maintain 'overweight' ratings on the stock, signaling confidence in its long-term prospects.
- High Note Wealth LLC increased its position by 50%, while other hedge funds like Prosperity Consulting Group boosted stakes.
Risk Factors
- Royal Bank of Canada lowered its price target from $650 to $600, citing a more conservative valuation outlook.
- Bank of America decreased its price target from $520 to $515, reflecting a slight adjustment in near-term expectations.
Full Analysis
Intuitive Surgical (NASDAQ:ISRG) EVP Mark Brosius sold 46 shares of the company's stock on September 8th under a pre-arranged Rule 10b5-1 trading plan. The transaction, valued at $16,616.58, reduced his personal holding by 5.22%, leaving him with 835 shares worth approximately $301,627. This insider sale is a routine disclosure event and does not necessarily indicate a change in the company's long-term outlook.
The medical technology firm recently reported strong quarterly financial results released on July 16th. Intuitive Surgical generated revenue of $2.89 billion, surpassing analyst consensus estimates of $2.83 billion, while posting earnings per share (EPS) of $2.80 against an expected $2.48. The company's revenue grew by 18.4% year-over-year, driven by its da Vinci Surgical System used across various surgical specialties.
Analyst sentiment remains mixed but generally positive regarding the stock's valuation and growth trajectory. While Royal Bank of Canada lowered its price target to $600 and Bank of America reduced theirs to $515, major institutions like KeyCorp and Piper Sandler maintain 'overweight' or 'outperform' ratings. Institutional ownership stands at 83.64%, with several hedge funds increasing their stakes in the fourth quarter.
